Bicalutamide (Binarex) 50 mg tablets: Supply issue

Supply issue Active

Rex Medical, the supplier, is out of stock of bicalutamide (Binarex) because of a manufacturing delay.

7 February 2024 update

The supplier expects stock of the alternative, Apo-Bicalumatide, to start being released to wholesalers in the week beginning 12 February 2024. It can take another 1 to 2 weeks for stock to start reaching pharmacies. 

Affected product

Because of a manufacturing delay, Rex Medical are out of stock of:

  • Chemical: Bicalutamide
  • Presentation: Tab 50 mg
  • Brand: Binarex
  • Pharmacode: 2523655
  • Subsidy: $4.18
  • Measure / Qty: per 28

Alternative product

We have funded a section 29 alternative from 1 February 2024. Supplies of this should arrive in Aotearoa by mid-February. It may take another week or two for stock to make its way to pharmacies.

  • Brand: Apo-Bicalutamide (Section 29)
  • Pharmacode: 2672111
  • Subsidy: $4.18
  • Measure / Qty: per 28

Prescribing and supplying an unapproved medicine

Section 29 of the Medicines Act 1981 allows for medicines that are not Medsafe approved to be prescribed and supplied to people. The medicine must be prescribed by someone registered with the Medical Council of New Zealand – such as, a doctor. 

We know supplying a medicine under section 29 is not ideal. In this case, however, this will allow patients to be able to access an appropriate treatment. 

We apologise for any inconvenience this causes. 

Advice for prescribing under section 29 – BPAC website(external link) 

Prescriber and pharmacist requirements for section 29 medicines – Medsafe website (external link)

Medsafe’s section 29 Declaration / Notification Form [DOC](external link)

What patients need to know about unapproved medicines – Healthify website(external link)

Expected resupply 

Rex Medical expect to be able to supply the registered product by the end of February or early March 2024.

Who to contact

If you have questions about this issue, email enquiry@pharmac.govt.nz

Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.  

Sign up to our email list for regular emails about supply issues and more(external link)